Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
5-Nitrouracil stabilizes the plasma concentration values of 5-FU in colorectal cancer patients receiving capecitabine.
Yoshida Y, Hashimoto Y, Miyazaki M, Aisu N, Yamada T, Kajitani R, Munechika T, Matsumoto Y, Nagano H, Shimaoka H, Komono A, Sakamoto R, Yoshimatsu G, Yoshimura F, Kiyomi F, Hasegawa S. Yoshida Y, et al. Among authors: kiyomi f. Sci Rep. 2020 Feb 17;10(1):2711. doi: 10.1038/s41598-020-59648-2. Sci Rep. 2020. PMID: 32066801 Free PMC article.
Rationale and design of a phase II study to evaluate prophylactic treatment of dacomitinib-induced dermatologic adverse events in epidermal growth factor receptor-mutated advanced non-small cell lung cancer (SPIRAL-Daco study).
Iwasaku M, Uchino J, Yamada T, Chihara Y, Shimamoto T, Tamiya N, Kaneko Y, Kiyomi F, Takayama K. Iwasaku M, et al. Among authors: kiyomi f. Transl Lung Cancer Res. 2019 Aug;8(4):519-523. doi: 10.21037/tlcr.2019.08.03. Transl Lung Cancer Res. 2019. PMID: 31555524 Free PMC article.
A phase 2 trial of durvalumab treatment following radiation monotherapy in patients with non-small cell lung cancer ineligible for stage III chemoradiotherapy: The SPIRAL-RT study.
Yamada T, Goto Y, Tanaka H, Kimura H, Minato K, Gyotoku H, Honda T, Watanabe S, Morimoto K, Kiyomi F, Uchino J, Takayama K. Yamada T, et al. Among authors: kiyomi f. Eur J Cancer. 2023 Dec;195:113373. doi: 10.1016/j.ejca.2023.113373. Epub 2023 Oct 22. Eur J Cancer. 2023. PMID: 37890349 Free article. Clinical Trial.
Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study.
Nakamura Y, Kitamura T, Kiyomi F, Hayakawa M, Hoshino K, Kawano Y, Yamasaki R, Nishida T, Mizunuma M, Ishikura H; Japan Septic Disseminated Intravascular Coagulation (JSEPTIC DIC) study group. Nakamura Y, et al. Among authors: kiyomi f. Crit Care. 2017 Jun 7;21(1):134. doi: 10.1186/s13054-017-1712-3. Crit Care. 2017. PMID: 28592318 Free PMC article.
33 results